Trusted Resources: Education
Scientific literature and patient education texts
Analysis of Cognitive Ability and Adaptive Behavior Assessment Tools Used in an Observational Study of Patients With Mucopolysaccharidosis II
source: Orphanet journal of rare diseases
year: 2021
authors: Yee KS,Wu Y,Harrington M,Waisbren SE
summary/abstract:Mucopolysaccharidosis II (MPS II) is a rare lysosomal storage disease characterized by cognitive impairment in most patients. This post hoc analysis evaluated changes in cognitive function, adaptive behavior and functional outcomes in patients with neuronopathic MPS II over time. Fifty-five children with MPS II were enrolled in a 24-month observational study (NCT01822184). The Differential Ability Scales, second edition (DAS-II; early years battery for ages 2 years 6 months to 6 years 11 months, school age battery for ages 7 years to 17 years 11 months), Vineland Adaptive Behavior Scales, second edition (VABS-II) and the Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) were performed at baseline and 3-month intervals over 2 years. A subgroup of 38 children with a DAS-II General Conceptual Ability (GCA) score of 55-85 (below average-very low abilities) at any time during the study were included in this analysis.
organization: Takeda Development Center Americas, Inc., Cambridge, MA, USA. [email protected].DOI: 10.1186/s13023-021-02118-3
read more
Related Content
-
Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration With JCR PharmaceuticalsTakeda Pharmaceutical Company Limited an...
-
Hunting Hunter Syndrome: A Rare Disease Hidden Among Childhood Complaintshttps://www.youtube.com/watch?v=QJYy4wbV...
-
Surgical Management of an Aortic Root Dilatation in a Patient Suffering From Hunter SyndromeHunter syndrome is a rare disease leadin...
-
Convergent Molecular Mechanisms Underlying Cognitive Impairment in Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II) i...
-
Enzyme Replacement Therapy With Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis o...Enzyme replacement therapy (ERT) improve...
-
Emily Wants to Show Other Caregivers the Importance of Taking Care of YourselfPeople often make admiring comments to c...
-
Hunter Syndrome (MPS II): An Uncommon Combination of Childhood Complaintshttps://www.youtube.com/watch?v=7kBGEYAF...